Real-time enrollment status for this alzheimer s disease clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 11:30 PM UTC
| NCT Number | NCT07701161 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer s Disease |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Neurogen Biomarking LLC |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 31, 2026: Clinical trial NCT07701161 is currently recruiting participants. This clinical trial study for alzheimer s disease is actively seeking new participants at 5 locations across the United States. The study is sponsored by Neurogen Biomarking LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07701161 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07701161 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.